Lesion-based analysis of F-18-FDG uptake and In-111-Pentetreotide uptake by neuroendocrine tumors

摘要

To characterize the heterogeneity of metastatic neuroendocrine tumor (NET) lesions, we compared the [F-18]-fluorodeoxyglucose (FDG) uptake and the In-111-pentetreotide (SRS) uptake for somatostatin receptor scintigraphy using the CT-based fusion imaging techniques of PET/CT and SPECT/CT.